nodes	percent_of_prediction	percent_of_DWPC	metapath
Voriconazole—FMO1—Vandetanib—thyroid cancer	0.408	0.514	CbGbCtD
Voriconazole—FMO3—Vandetanib—thyroid cancer	0.255	0.321	CbGbCtD
Voriconazole—CYP3A7—Sorafenib—thyroid cancer	0.0206	0.026	CbGbCtD
Voriconazole—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0206	0.026	CbGbCtD
Voriconazole—CYP2B6—Sorafenib—thyroid cancer	0.0196	0.0247	CbGbCtD
Voriconazole—CYP3A5—Sorafenib—thyroid cancer	0.0154	0.0195	CbGbCtD
Voriconazole—CYP2C19—Sorafenib—thyroid cancer	0.0124	0.0157	CbGbCtD
Voriconazole—CYP2B6—Doxorubicin—thyroid cancer	0.0119	0.015	CbGbCtD
Voriconazole—CYP2C9—Sorafenib—thyroid cancer	0.0103	0.0131	CbGbCtD
Voriconazole—CYP3A4—Vandetanib—thyroid cancer	0.00998	0.0126	CbGbCtD
Voriconazole—CYP3A4—Sorafenib—thyroid cancer	0.00602	0.00759	CbGbCtD
Voriconazole—CYP3A4—Doxorubicin—thyroid cancer	0.00365	0.00461	CbGbCtD
Voriconazole—PTGS1—Eicosanoid Synthesis—PTGES2—thyroid cancer	0.00147	0.105	CbGpPWpGaD
Voriconazole—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—thyroid cancer	0.0011	0.0789	CbGpPWpGaD
Voriconazole—FMO1—Metapathway biotransformation—CHST14—thyroid cancer	0.000646	0.0463	CbGpPWpGaD
Voriconazole—PTGS1—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.000599	0.0429	CbGpPWpGaD
Voriconazole—FMO3—Metapathway biotransformation—CHST14—thyroid cancer	0.000462	0.0331	CbGpPWpGaD
Voriconazole—PTGS1—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000398	0.0285	CbGpPWpGaD
Voriconazole—CYP2B6—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000397	0.0285	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—RET—thyroid cancer	0.000373	0.0267	CbGpPWpGaD
Voriconazole—FMO1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000359	0.0257	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.000347	0.0249	CbGpPWpGaD
Voriconazole—FMO3—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000257	0.0184	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000231	0.0165	CbGpPWpGaD
Voriconazole—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000229	0.0164	CbGpPWpGaD
Voriconazole—CYP2C9—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000209	0.015	CbGpPWpGaD
Voriconazole—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—thyroid cancer	0.000198	0.0142	CbGpPWpGaD
Voriconazole—FMO1—Biological oxidations—RXRA—thyroid cancer	0.000191	0.0137	CbGpPWpGaD
Voriconazole—CYP3A7—Metapathway biotransformation—CHST14—thyroid cancer	0.000187	0.0134	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000182	0.0131	CbGpPWpGaD
Voriconazole—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000181	0.0129	CbGpPWpGaD
Voriconazole—CYP2B6—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000157	0.0112	CbGpPWpGaD
Voriconazole—PTGS1—Overview of nanoparticle effects—PTGS2—thyroid cancer	0.000155	0.0111	CbGpPWpGaD
Voriconazole—CYP3A5—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000153	0.011	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—MINPP1—thyroid cancer	0.00014	0.01	CbGpPWpGaD
Voriconazole—CYP2B6—Metapathway biotransformation—CHST14—thyroid cancer	0.000138	0.0099	CbGpPWpGaD
Voriconazole—FMO3—Biological oxidations—RXRA—thyroid cancer	0.000136	0.00977	CbGpPWpGaD
Voriconazole—CYP3A5—Metapathway biotransformation—CHST14—thyroid cancer	0.000135	0.00968	CbGpPWpGaD
Voriconazole—Ataxia—Epirubicin—thyroid cancer	0.000132	0.000681	CcSEcCtD
Voriconazole—Blood creatinine increased—Epirubicin—thyroid cancer	0.000131	0.000678	CcSEcCtD
Voriconazole—Hyponatraemia—Doxorubicin—thyroid cancer	0.00013	0.000673	CcSEcCtD
Voriconazole—Diplopia—Doxorubicin—thyroid cancer	0.00013	0.00067	CcSEcCtD
Voriconazole—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.00013	0.00067	CcSEcCtD
Voriconazole—Liver function test abnormal—Epirubicin—thyroid cancer	0.000129	0.000669	CcSEcCtD
Voriconazole—PTGS1—Eicosanoid Synthesis—PTGS2—thyroid cancer	0.000128	0.0092	CbGpPWpGaD
Voriconazole—Dry skin—Epirubicin—thyroid cancer	0.000128	0.000664	CcSEcCtD
Voriconazole—CYP3A7—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000128	0.00918	CbGpPWpGaD
Voriconazole—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000128	0.000661	CcSEcCtD
Voriconazole—Hypokalaemia—Epirubicin—thyroid cancer	0.000127	0.000659	CcSEcCtD
Voriconazole—Diarrhoea—Sorafenib—thyroid cancer	0.000127	0.000659	CcSEcCtD
Voriconazole—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000126	0.000652	CcSEcCtD
Voriconazole—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000126	0.000652	CcSEcCtD
Voriconazole—Face oedema—Doxorubicin—thyroid cancer	0.000125	0.000647	CcSEcCtD
Voriconazole—Muscular weakness—Epirubicin—thyroid cancer	0.000124	0.000639	CcSEcCtD
Voriconazole—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000124	0.000639	CcSEcCtD
Voriconazole—Cardiac arrest—Doxorubicin—thyroid cancer	0.000123	0.000637	CcSEcCtD
Voriconazole—Dizziness—Sorafenib—thyroid cancer	0.000123	0.000637	CcSEcCtD
Voriconazole—Abdominal distension—Epirubicin—thyroid cancer	0.000122	0.00063	CcSEcCtD
Voriconazole—Ataxia—Doxorubicin—thyroid cancer	0.000122	0.00063	CcSEcCtD
Voriconazole—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000121	0.000628	CcSEcCtD
Voriconazole—Dysphagia—Epirubicin—thyroid cancer	0.000121	0.000626	CcSEcCtD
Voriconazole—Influenza—Epirubicin—thyroid cancer	0.000121	0.000626	CcSEcCtD
Voriconazole—Eosinophilia—Epirubicin—thyroid cancer	0.00012	0.00062	CcSEcCtD
Voriconazole—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00012	0.000619	CcSEcCtD
Voriconazole—FMO1—Metabolism—NDUFA13—thyroid cancer	0.000119	0.00854	CbGpPWpGaD
Voriconazole—Dry skin—Doxorubicin—thyroid cancer	0.000119	0.000614	CcSEcCtD
Voriconazole—Pancreatitis—Epirubicin—thyroid cancer	0.000119	0.000614	CcSEcCtD
Voriconazole—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000118	0.00848	CbGpPWpGaD
Voriconazole—Vomiting—Sorafenib—thyroid cancer	0.000118	0.000612	CcSEcCtD
Voriconazole—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000118	0.000612	CcSEcCtD
Voriconazole—Hypokalaemia—Doxorubicin—thyroid cancer	0.000118	0.00061	CcSEcCtD
Voriconazole—Rash—Sorafenib—thyroid cancer	0.000117	0.000607	CcSEcCtD
Voriconazole—Dermatitis—Sorafenib—thyroid cancer	0.000117	0.000607	CcSEcCtD
Voriconazole—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000117	0.000603	CcSEcCtD
Voriconazole—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000117	0.000603	CcSEcCtD
Voriconazole—Headache—Sorafenib—thyroid cancer	0.000117	0.000603	CcSEcCtD
Voriconazole—Pancytopenia—Epirubicin—thyroid cancer	0.000115	0.000594	CcSEcCtD
Voriconazole—Muscular weakness—Doxorubicin—thyroid cancer	0.000114	0.000591	CcSEcCtD
Voriconazole—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000114	0.000591	CcSEcCtD
Voriconazole—Dysuria—Epirubicin—thyroid cancer	0.000113	0.000585	CcSEcCtD
Voriconazole—Abdominal distension—Doxorubicin—thyroid cancer	0.000113	0.000583	CcSEcCtD
Voriconazole—FMO1—Metabolism—CHST14—thyroid cancer	0.000112	0.00802	CbGpPWpGaD
Voriconazole—Influenza—Doxorubicin—thyroid cancer	0.000112	0.000579	CcSEcCtD
Voriconazole—Dysphagia—Doxorubicin—thyroid cancer	0.000112	0.000579	CcSEcCtD
Voriconazole—Eosinophilia—Doxorubicin—thyroid cancer	0.000111	0.000573	CcSEcCtD
Voriconazole—Nausea—Sorafenib—thyroid cancer	0.000111	0.000572	CcSEcCtD
Voriconazole—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000111	0.000571	CcSEcCtD
Voriconazole—Pancreatitis—Doxorubicin—thyroid cancer	0.00011	0.000568	CcSEcCtD
Voriconazole—FMO3—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000109	0.00784	CbGpPWpGaD
Voriconazole—Hyperglycaemia—Epirubicin—thyroid cancer	0.000109	0.000565	CcSEcCtD
Voriconazole—Pneumonia—Epirubicin—thyroid cancer	0.000109	0.000561	CcSEcCtD
Voriconazole—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000108	0.00774	CbGpPWpGaD
Voriconazole—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000108	0.00774	CbGpPWpGaD
Voriconazole—Infestation NOS—Epirubicin—thyroid cancer	0.000108	0.000558	CcSEcCtD
Voriconazole—Infestation—Epirubicin—thyroid cancer	0.000108	0.000558	CcSEcCtD
Voriconazole—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.000107	0.0077	CbGpPWpGaD
Voriconazole—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000107	0.000553	CcSEcCtD
Voriconazole—Pancytopenia—Doxorubicin—thyroid cancer	0.000106	0.00055	CcSEcCtD
Voriconazole—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000106	0.000547	CcSEcCtD
Voriconazole—Stomatitis—Epirubicin—thyroid cancer	0.000105	0.000544	CcSEcCtD
Voriconazole—Jaundice—Epirubicin—thyroid cancer	0.000105	0.000544	CcSEcCtD
Voriconazole—Conjunctivitis—Epirubicin—thyroid cancer	0.000105	0.000542	CcSEcCtD
Voriconazole—Urinary tract infection—Epirubicin—thyroid cancer	0.000105	0.000542	CcSEcCtD
Voriconazole—Dysuria—Doxorubicin—thyroid cancer	0.000105	0.000542	CcSEcCtD
Voriconazole—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.000104	0.00748	CbGpPWpGaD
Voriconazole—CYP3A7—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000104	0.00744	CbGpPWpGaD
Voriconazole—Sweating—Epirubicin—thyroid cancer	0.000103	0.000535	CcSEcCtD
Voriconazole—Haematuria—Epirubicin—thyroid cancer	0.000103	0.000532	CcSEcCtD
Voriconazole—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000102	0.000529	CcSEcCtD
Voriconazole—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000102	0.000528	CcSEcCtD
Voriconazole—Epistaxis—Epirubicin—thyroid cancer	0.000102	0.000526	CcSEcCtD
Voriconazole—Sinusitis—Epirubicin—thyroid cancer	0.000101	0.000524	CcSEcCtD
Voriconazole—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000101	0.000522	CcSEcCtD
Voriconazole—Agranulocytosis—Epirubicin—thyroid cancer	0.000101	0.000521	CcSEcCtD
Voriconazole—PTGS1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000101	0.00721	CbGpPWpGaD
Voriconazole—Pneumonia—Doxorubicin—thyroid cancer	0.0001	0.000519	CcSEcCtD
Voriconazole—FMO3—Metabolism—MINPP1—thyroid cancer	0.0001	0.00718	CbGpPWpGaD
Voriconazole—Infestation NOS—Doxorubicin—thyroid cancer	9.99e-05	0.000516	CcSEcCtD
Voriconazole—Infestation—Doxorubicin—thyroid cancer	9.99e-05	0.000516	CcSEcCtD
Voriconazole—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	9.9e-05	0.000512	CcSEcCtD
Voriconazole—Bradycardia—Epirubicin—thyroid cancer	9.86e-05	0.00051	CcSEcCtD
Voriconazole—Neuropathy peripheral—Doxorubicin—thyroid cancer	9.79e-05	0.000506	CcSEcCtD
Voriconazole—Jaundice—Doxorubicin—thyroid cancer	9.74e-05	0.000503	CcSEcCtD
Voriconazole—Stomatitis—Doxorubicin—thyroid cancer	9.74e-05	0.000503	CcSEcCtD
Voriconazole—Rhinitis—Epirubicin—thyroid cancer	9.71e-05	0.000502	CcSEcCtD
Voriconazole—Urinary tract infection—Doxorubicin—thyroid cancer	9.71e-05	0.000502	CcSEcCtD
Voriconazole—Conjunctivitis—Doxorubicin—thyroid cancer	9.71e-05	0.000502	CcSEcCtD
Voriconazole—Hepatitis—Epirubicin—thyroid cancer	9.69e-05	0.000501	CcSEcCtD
Voriconazole—Hypoaesthesia—Epirubicin—thyroid cancer	9.64e-05	0.000498	CcSEcCtD
Voriconazole—Pharyngitis—Epirubicin—thyroid cancer	9.62e-05	0.000497	CcSEcCtD
Voriconazole—Sweating—Doxorubicin—thyroid cancer	9.57e-05	0.000495	CcSEcCtD
Voriconazole—Urinary tract disorder—Epirubicin—thyroid cancer	9.57e-05	0.000495	CcSEcCtD
Voriconazole—Oedema peripheral—Epirubicin—thyroid cancer	9.55e-05	0.000494	CcSEcCtD
Voriconazole—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	9.53e-05	0.00682	CbGpPWpGaD
Voriconazole—Haematuria—Doxorubicin—thyroid cancer	9.52e-05	0.000492	CcSEcCtD
Voriconazole—Connective tissue disorder—Epirubicin—thyroid cancer	9.52e-05	0.000492	CcSEcCtD
Voriconazole—Urethral disorder—Epirubicin—thyroid cancer	9.5e-05	0.000491	CcSEcCtD
Voriconazole—CYP2B6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	9.48e-05	0.00679	CbGpPWpGaD
Voriconazole—Hepatobiliary disease—Doxorubicin—thyroid cancer	9.45e-05	0.000488	CcSEcCtD
Voriconazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	9.43e-05	0.00675	CbGpPWpGaD
Voriconazole—Epistaxis—Doxorubicin—thyroid cancer	9.42e-05	0.000487	CcSEcCtD
Voriconazole—Sinusitis—Doxorubicin—thyroid cancer	9.37e-05	0.000484	CcSEcCtD
Voriconazole—Visual impairment—Epirubicin—thyroid cancer	9.34e-05	0.000483	CcSEcCtD
Voriconazole—Agranulocytosis—Doxorubicin—thyroid cancer	9.32e-05	0.000482	CcSEcCtD
Voriconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	9.27e-05	0.00664	CbGpPWpGaD
Voriconazole—Erythema multiforme—Epirubicin—thyroid cancer	9.16e-05	0.000474	CcSEcCtD
Voriconazole—Bradycardia—Doxorubicin—thyroid cancer	9.13e-05	0.000472	CcSEcCtD
Voriconazole—Eye disorder—Epirubicin—thyroid cancer	9.06e-05	0.000468	CcSEcCtD
Voriconazole—Tinnitus—Epirubicin—thyroid cancer	9.03e-05	0.000467	CcSEcCtD
Voriconazole—FMO1—Metabolism—HPGD—thyroid cancer	9.03e-05	0.00647	CbGpPWpGaD
Voriconazole—Flushing—Epirubicin—thyroid cancer	8.99e-05	0.000465	CcSEcCtD
Voriconazole—Cardiac disorder—Epirubicin—thyroid cancer	8.99e-05	0.000465	CcSEcCtD
Voriconazole—Rhinitis—Doxorubicin—thyroid cancer	8.99e-05	0.000465	CcSEcCtD
Voriconazole—Hepatitis—Doxorubicin—thyroid cancer	8.97e-05	0.000464	CcSEcCtD
Voriconazole—Hypoaesthesia—Doxorubicin—thyroid cancer	8.92e-05	0.000461	CcSEcCtD
Voriconazole—Pharyngitis—Doxorubicin—thyroid cancer	8.9e-05	0.00046	CcSEcCtD
Voriconazole—Urinary tract disorder—Doxorubicin—thyroid cancer	8.85e-05	0.000458	CcSEcCtD
Voriconazole—Oedema peripheral—Doxorubicin—thyroid cancer	8.83e-05	0.000457	CcSEcCtD
Voriconazole—Connective tissue disorder—Doxorubicin—thyroid cancer	8.81e-05	0.000456	CcSEcCtD
Voriconazole—Angiopathy—Epirubicin—thyroid cancer	8.79e-05	0.000455	CcSEcCtD
Voriconazole—Urethral disorder—Doxorubicin—thyroid cancer	8.79e-05	0.000454	CcSEcCtD
Voriconazole—Immune system disorder—Epirubicin—thyroid cancer	8.75e-05	0.000452	CcSEcCtD
Voriconazole—Mediastinal disorder—Epirubicin—thyroid cancer	8.73e-05	0.000451	CcSEcCtD
Voriconazole—Chills—Epirubicin—thyroid cancer	8.69e-05	0.00045	CcSEcCtD
Voriconazole—Arrhythmia—Epirubicin—thyroid cancer	8.66e-05	0.000448	CcSEcCtD
Voriconazole—Visual impairment—Doxorubicin—thyroid cancer	8.64e-05	0.000447	CcSEcCtD
Voriconazole—Alopecia—Epirubicin—thyroid cancer	8.56e-05	0.000443	CcSEcCtD
Voriconazole—FMO3—Metabolism—NDUFA13—thyroid cancer	8.52e-05	0.0061	CbGpPWpGaD
Voriconazole—Mental disorder—Epirubicin—thyroid cancer	8.49e-05	0.000439	CcSEcCtD
Voriconazole—Erythema multiforme—Doxorubicin—thyroid cancer	8.48e-05	0.000438	CcSEcCtD
Voriconazole—Malnutrition—Epirubicin—thyroid cancer	8.44e-05	0.000436	CcSEcCtD
Voriconazole—Erythema—Epirubicin—thyroid cancer	8.44e-05	0.000436	CcSEcCtD
Voriconazole—Eye disorder—Doxorubicin—thyroid cancer	8.38e-05	0.000433	CcSEcCtD
Voriconazole—Tinnitus—Doxorubicin—thyroid cancer	8.36e-05	0.000432	CcSEcCtD
Voriconazole—Flushing—Doxorubicin—thyroid cancer	8.32e-05	0.00043	CcSEcCtD
Voriconazole—Cardiac disorder—Doxorubicin—thyroid cancer	8.32e-05	0.00043	CcSEcCtD
Voriconazole—Flatulence—Epirubicin—thyroid cancer	8.31e-05	0.00043	CcSEcCtD
Voriconazole—Dysgeusia—Epirubicin—thyroid cancer	8.26e-05	0.000427	CcSEcCtD
Voriconazole—Back pain—Epirubicin—thyroid cancer	8.16e-05	0.000422	CcSEcCtD
Voriconazole—Angiopathy—Doxorubicin—thyroid cancer	8.13e-05	0.000421	CcSEcCtD
Voriconazole—Muscle spasms—Epirubicin—thyroid cancer	8.11e-05	0.000419	CcSEcCtD
Voriconazole—Immune system disorder—Doxorubicin—thyroid cancer	8.1e-05	0.000419	CcSEcCtD
Voriconazole—Mediastinal disorder—Doxorubicin—thyroid cancer	8.08e-05	0.000418	CcSEcCtD
Voriconazole—Chills—Doxorubicin—thyroid cancer	8.04e-05	0.000416	CcSEcCtD
Voriconazole—Arrhythmia—Doxorubicin—thyroid cancer	8.01e-05	0.000414	CcSEcCtD
Voriconazole—FMO3—Metabolism—CHST14—thyroid cancer	8.01e-05	0.00574	CbGpPWpGaD
Voriconazole—Vision blurred—Epirubicin—thyroid cancer	7.95e-05	0.000411	CcSEcCtD
Voriconazole—Alopecia—Doxorubicin—thyroid cancer	7.92e-05	0.00041	CcSEcCtD
Voriconazole—Mental disorder—Doxorubicin—thyroid cancer	7.85e-05	0.000406	CcSEcCtD
Voriconazole—Ill-defined disorder—Epirubicin—thyroid cancer	7.83e-05	0.000405	CcSEcCtD
Voriconazole—Erythema—Doxorubicin—thyroid cancer	7.8e-05	0.000404	CcSEcCtD
Voriconazole—Malnutrition—Doxorubicin—thyroid cancer	7.8e-05	0.000404	CcSEcCtD
Voriconazole—Anaemia—Epirubicin—thyroid cancer	7.8e-05	0.000403	CcSEcCtD
Voriconazole—Agitation—Epirubicin—thyroid cancer	7.75e-05	0.000401	CcSEcCtD
Voriconazole—Flatulence—Doxorubicin—thyroid cancer	7.69e-05	0.000398	CcSEcCtD
Voriconazole—CYP2B6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	7.69e-05	0.0055	CbGpPWpGaD
Voriconazole—Dysgeusia—Doxorubicin—thyroid cancer	7.64e-05	0.000395	CcSEcCtD
Voriconazole—Malaise—Epirubicin—thyroid cancer	7.61e-05	0.000393	CcSEcCtD
Voriconazole—Vertigo—Epirubicin—thyroid cancer	7.58e-05	0.000392	CcSEcCtD
Voriconazole—Syncope—Epirubicin—thyroid cancer	7.56e-05	0.000391	CcSEcCtD
Voriconazole—Leukopenia—Epirubicin—thyroid cancer	7.55e-05	0.00039	CcSEcCtD
Voriconazole—Back pain—Doxorubicin—thyroid cancer	7.55e-05	0.00039	CcSEcCtD
Voriconazole—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	7.51e-05	0.00538	CbGpPWpGaD
Voriconazole—Muscle spasms—Doxorubicin—thyroid cancer	7.5e-05	0.000388	CcSEcCtD
Voriconazole—Palpitations—Epirubicin—thyroid cancer	7.45e-05	0.000385	CcSEcCtD
Voriconazole—Loss of consciousness—Epirubicin—thyroid cancer	7.41e-05	0.000383	CcSEcCtD
Voriconazole—Cough—Epirubicin—thyroid cancer	7.36e-05	0.000381	CcSEcCtD
Voriconazole—Vision blurred—Doxorubicin—thyroid cancer	7.36e-05	0.00038	CcSEcCtD
Voriconazole—Convulsion—Epirubicin—thyroid cancer	7.31e-05	0.000378	CcSEcCtD
Voriconazole—Hypertension—Epirubicin—thyroid cancer	7.28e-05	0.000377	CcSEcCtD
Voriconazole—Ill-defined disorder—Doxorubicin—thyroid cancer	7.24e-05	0.000374	CcSEcCtD
Voriconazole—Anaemia—Doxorubicin—thyroid cancer	7.21e-05	0.000373	CcSEcCtD
Voriconazole—Arthralgia—Epirubicin—thyroid cancer	7.18e-05	0.000371	CcSEcCtD
Voriconazole—Chest pain—Epirubicin—thyroid cancer	7.18e-05	0.000371	CcSEcCtD
Voriconazole—Myalgia—Epirubicin—thyroid cancer	7.18e-05	0.000371	CcSEcCtD
Voriconazole—Agitation—Doxorubicin—thyroid cancer	7.17e-05	0.000371	CcSEcCtD
Voriconazole—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	7.16e-05	0.00513	CbGpPWpGaD
Voriconazole—Anxiety—Epirubicin—thyroid cancer	7.16e-05	0.00037	CcSEcCtD
Voriconazole—PTGS1—Arachidonic acid metabolism—PTGS2—thyroid cancer	7.14e-05	0.00511	CbGpPWpGaD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	7.13e-05	0.000369	CcSEcCtD
Voriconazole—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	7.12e-05	0.0051	CbGpPWpGaD
Voriconazole—Discomfort—Epirubicin—thyroid cancer	7.1e-05	0.000367	CcSEcCtD
Voriconazole—Malaise—Doxorubicin—thyroid cancer	7.04e-05	0.000364	CcSEcCtD
Voriconazole—Dry mouth—Epirubicin—thyroid cancer	7.02e-05	0.000363	CcSEcCtD
Voriconazole—Vertigo—Doxorubicin—thyroid cancer	7.01e-05	0.000363	CcSEcCtD
Voriconazole—Syncope—Doxorubicin—thyroid cancer	7e-05	0.000362	CcSEcCtD
Voriconazole—Leukopenia—Doxorubicin—thyroid cancer	6.99e-05	0.000361	CcSEcCtD
Voriconazole—Confusional state—Epirubicin—thyroid cancer	6.94e-05	0.000359	CcSEcCtD
Voriconazole—Palpitations—Doxorubicin—thyroid cancer	6.9e-05	0.000357	CcSEcCtD
Voriconazole—Anaphylactic shock—Epirubicin—thyroid cancer	6.88e-05	0.000356	CcSEcCtD
Voriconazole—Oedema—Epirubicin—thyroid cancer	6.88e-05	0.000356	CcSEcCtD
Voriconazole—Loss of consciousness—Doxorubicin—thyroid cancer	6.86e-05	0.000355	CcSEcCtD
Voriconazole—Infection—Epirubicin—thyroid cancer	6.84e-05	0.000354	CcSEcCtD
Voriconazole—Cough—Doxorubicin—thyroid cancer	6.81e-05	0.000352	CcSEcCtD
Voriconazole—Shock—Epirubicin—thyroid cancer	6.77e-05	0.00035	CcSEcCtD
Voriconazole—Convulsion—Doxorubicin—thyroid cancer	6.76e-05	0.00035	CcSEcCtD
Voriconazole—Nervous system disorder—Epirubicin—thyroid cancer	6.75e-05	0.000349	CcSEcCtD
Voriconazole—Thrombocytopenia—Epirubicin—thyroid cancer	6.74e-05	0.000348	CcSEcCtD
Voriconazole—Hypertension—Doxorubicin—thyroid cancer	6.74e-05	0.000348	CcSEcCtD
Voriconazole—Tachycardia—Epirubicin—thyroid cancer	6.72e-05	0.000347	CcSEcCtD
Voriconazole—Skin disorder—Epirubicin—thyroid cancer	6.69e-05	0.000346	CcSEcCtD
Voriconazole—Hyperhidrosis—Epirubicin—thyroid cancer	6.66e-05	0.000344	CcSEcCtD
Voriconazole—Arthralgia—Doxorubicin—thyroid cancer	6.64e-05	0.000344	CcSEcCtD
Voriconazole—Chest pain—Doxorubicin—thyroid cancer	6.64e-05	0.000344	CcSEcCtD
Voriconazole—Myalgia—Doxorubicin—thyroid cancer	6.64e-05	0.000344	CcSEcCtD
Voriconazole—Anxiety—Doxorubicin—thyroid cancer	6.62e-05	0.000342	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	6.6e-05	0.000341	CcSEcCtD
Voriconazole—Discomfort—Doxorubicin—thyroid cancer	6.57e-05	0.000339	CcSEcCtD
Voriconazole—Anorexia—Epirubicin—thyroid cancer	6.56e-05	0.000339	CcSEcCtD
Voriconazole—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	6.53e-05	0.00468	CbGpPWpGaD
Voriconazole—Dry mouth—Doxorubicin—thyroid cancer	6.5e-05	0.000336	CcSEcCtD
Voriconazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	6.5e-05	0.00465	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—HPGD—thyroid cancer	6.46e-05	0.00462	CbGpPWpGaD
Voriconazole—Hypotension—Epirubicin—thyroid cancer	6.43e-05	0.000333	CcSEcCtD
Voriconazole—Confusional state—Doxorubicin—thyroid cancer	6.42e-05	0.000332	CcSEcCtD
Voriconazole—Anaphylactic shock—Doxorubicin—thyroid cancer	6.37e-05	0.000329	CcSEcCtD
Voriconazole—Oedema—Doxorubicin—thyroid cancer	6.37e-05	0.000329	CcSEcCtD
Voriconazole—Infection—Doxorubicin—thyroid cancer	6.33e-05	0.000327	CcSEcCtD
Voriconazole—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	6.28e-05	0.0045	CbGpPWpGaD
Voriconazole—Musculoskeletal discomfort—Epirubicin—thyroid cancer	6.27e-05	0.000324	CcSEcCtD
Voriconazole—Shock—Doxorubicin—thyroid cancer	6.27e-05	0.000324	CcSEcCtD
Voriconazole—Nervous system disorder—Doxorubicin—thyroid cancer	6.25e-05	0.000323	CcSEcCtD
Voriconazole—Thrombocytopenia—Doxorubicin—thyroid cancer	6.24e-05	0.000322	CcSEcCtD
Voriconazole—Insomnia—Epirubicin—thyroid cancer	6.23e-05	0.000322	CcSEcCtD
Voriconazole—Tachycardia—Doxorubicin—thyroid cancer	6.22e-05	0.000321	CcSEcCtD
Voriconazole—Skin disorder—Doxorubicin—thyroid cancer	6.19e-05	0.00032	CcSEcCtD
Voriconazole—Paraesthesia—Epirubicin—thyroid cancer	6.18e-05	0.00032	CcSEcCtD
Voriconazole—Hyperhidrosis—Doxorubicin—thyroid cancer	6.16e-05	0.000318	CcSEcCtD
Voriconazole—Dyspnoea—Epirubicin—thyroid cancer	6.14e-05	0.000317	CcSEcCtD
Voriconazole—Somnolence—Epirubicin—thyroid cancer	6.12e-05	0.000316	CcSEcCtD
Voriconazole—Anorexia—Doxorubicin—thyroid cancer	6.07e-05	0.000314	CcSEcCtD
Voriconazole—Dyspepsia—Epirubicin—thyroid cancer	6.06e-05	0.000313	CcSEcCtD
Voriconazole—Decreased appetite—Epirubicin—thyroid cancer	5.98e-05	0.000309	CcSEcCtD
Voriconazole—Hypotension—Doxorubicin—thyroid cancer	5.95e-05	0.000308	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Epirubicin—thyroid cancer	5.94e-05	0.000307	CcSEcCtD
Voriconazole—Pain—Epirubicin—thyroid cancer	5.89e-05	0.000304	CcSEcCtD
Voriconazole—Constipation—Epirubicin—thyroid cancer	5.89e-05	0.000304	CcSEcCtD
Voriconazole—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	5.81e-05	0.00416	CbGpPWpGaD
Voriconazole—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	5.8e-05	0.0003	CcSEcCtD
Voriconazole—Insomnia—Doxorubicin—thyroid cancer	5.76e-05	0.000298	CcSEcCtD
Voriconazole—Paraesthesia—Doxorubicin—thyroid cancer	5.72e-05	0.000296	CcSEcCtD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.69e-05	0.00407	CbGpPWpGaD
Voriconazole—Dyspnoea—Doxorubicin—thyroid cancer	5.68e-05	0.000294	CcSEcCtD
Voriconazole—Feeling abnormal—Epirubicin—thyroid cancer	5.67e-05	0.000293	CcSEcCtD
Voriconazole—Somnolence—Doxorubicin—thyroid cancer	5.66e-05	0.000293	CcSEcCtD
Voriconazole—Gastrointestinal pain—Epirubicin—thyroid cancer	5.63e-05	0.000291	CcSEcCtD
Voriconazole—Dyspepsia—Doxorubicin—thyroid cancer	5.61e-05	0.00029	CcSEcCtD
Voriconazole—Decreased appetite—Doxorubicin—thyroid cancer	5.54e-05	0.000286	CcSEcCtD
Voriconazole—CYP3A7—Biological oxidations—RXRA—thyroid cancer	5.52e-05	0.00395	CbGpPWpGaD
Voriconazole—Gastrointestinal disorder—Doxorubicin—thyroid cancer	5.5e-05	0.000284	CcSEcCtD
Voriconazole—Urticaria—Epirubicin—thyroid cancer	5.47e-05	0.000283	CcSEcCtD
Voriconazole—Pain—Doxorubicin—thyroid cancer	5.45e-05	0.000282	CcSEcCtD
Voriconazole—Constipation—Doxorubicin—thyroid cancer	5.45e-05	0.000282	CcSEcCtD
Voriconazole—Body temperature increased—Epirubicin—thyroid cancer	5.44e-05	0.000281	CcSEcCtD
Voriconazole—Abdominal pain—Epirubicin—thyroid cancer	5.44e-05	0.000281	CcSEcCtD
Voriconazole—PTGS1—Biological oxidations—RXRA—thyroid cancer	5.35e-05	0.00383	CbGpPWpGaD
Voriconazole—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	5.3e-05	0.00379	CbGpPWpGaD
Voriconazole—Feeling abnormal—Doxorubicin—thyroid cancer	5.25e-05	0.000271	CcSEcCtD
Voriconazole—Gastrointestinal pain—Doxorubicin—thyroid cancer	5.21e-05	0.000269	CcSEcCtD
Voriconazole—FMO1—Metabolism—TPR—thyroid cancer	5.19e-05	0.00372	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—PRKAR1A—thyroid cancer	5.1e-05	0.00365	CbGpPWpGaD
Voriconazole—Hypersensitivity—Epirubicin—thyroid cancer	5.07e-05	0.000262	CcSEcCtD
Voriconazole—Urticaria—Doxorubicin—thyroid cancer	5.06e-05	0.000262	CcSEcCtD
Voriconazole—Abdominal pain—Doxorubicin—thyroid cancer	5.04e-05	0.00026	CcSEcCtD
Voriconazole—Body temperature increased—Doxorubicin—thyroid cancer	5.04e-05	0.00026	CcSEcCtD
Voriconazole—Asthenia—Epirubicin—thyroid cancer	4.94e-05	0.000255	CcSEcCtD
Voriconazole—Pruritus—Epirubicin—thyroid cancer	4.87e-05	0.000252	CcSEcCtD
Voriconazole—Diarrhoea—Epirubicin—thyroid cancer	4.71e-05	0.000244	CcSEcCtD
Voriconazole—Hypersensitivity—Doxorubicin—thyroid cancer	4.69e-05	0.000243	CcSEcCtD
Voriconazole—Asthenia—Doxorubicin—thyroid cancer	4.57e-05	0.000236	CcSEcCtD
Voriconazole—Dizziness—Epirubicin—thyroid cancer	4.55e-05	0.000235	CcSEcCtD
Voriconazole—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	4.54e-05	0.00325	CbGpPWpGaD
Voriconazole—Pruritus—Doxorubicin—thyroid cancer	4.51e-05	0.000233	CcSEcCtD
Voriconazole—Vomiting—Epirubicin—thyroid cancer	4.38e-05	0.000226	CcSEcCtD
Voriconazole—Diarrhoea—Doxorubicin—thyroid cancer	4.36e-05	0.000225	CcSEcCtD
Voriconazole—Rash—Epirubicin—thyroid cancer	4.34e-05	0.000224	CcSEcCtD
Voriconazole—Dermatitis—Epirubicin—thyroid cancer	4.34e-05	0.000224	CcSEcCtD
Voriconazole—Headache—Epirubicin—thyroid cancer	4.31e-05	0.000223	CcSEcCtD
Voriconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	4.31e-05	0.00309	CbGpPWpGaD
Voriconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	4.28e-05	0.00307	CbGpPWpGaD
Voriconazole—Dizziness—Doxorubicin—thyroid cancer	4.21e-05	0.000218	CcSEcCtD
Voriconazole—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	4.12e-05	0.00295	CbGpPWpGaD
Voriconazole—Nausea—Epirubicin—thyroid cancer	4.09e-05	0.000211	CcSEcCtD
Voriconazole—CYP2B6—Biological oxidations—RXRA—thyroid cancer	4.08e-05	0.00292	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—MINPP1—thyroid cancer	4.06e-05	0.0029	CbGpPWpGaD
Voriconazole—Vomiting—Doxorubicin—thyroid cancer	4.05e-05	0.000209	CcSEcCtD
Voriconazole—Rash—Doxorubicin—thyroid cancer	4.02e-05	0.000208	CcSEcCtD
Voriconazole—Dermatitis—Doxorubicin—thyroid cancer	4.01e-05	0.000207	CcSEcCtD
Voriconazole—Headache—Doxorubicin—thyroid cancer	3.99e-05	0.000206	CcSEcCtD
Voriconazole—CYP3A5—Biological oxidations—RXRA—thyroid cancer	3.99e-05	0.00286	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—MINPP1—thyroid cancer	3.93e-05	0.00282	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—SLC5A5—thyroid cancer	3.88e-05	0.00278	CbGpPWpGaD
Voriconazole—Nausea—Doxorubicin—thyroid cancer	3.78e-05	0.000196	CcSEcCtD
Voriconazole—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	3.75e-05	0.00269	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—TPR—thyroid cancer	3.71e-05	0.00266	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—PRKAR1A—thyroid cancer	3.65e-05	0.00261	CbGpPWpGaD
Voriconazole—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	3.49e-05	0.0025	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—NDUFA13—thyroid cancer	3.45e-05	0.00247	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—NDUFA13—thyroid cancer	3.34e-05	0.00239	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	3.28e-05	0.00235	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—RXRA—thyroid cancer	3.26e-05	0.00234	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—CHST14—thyroid cancer	3.24e-05	0.00232	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—CHST14—thyroid cancer	3.14e-05	0.00225	CbGpPWpGaD
Voriconazole—CYP2C19—Biological oxidations—RXRA—thyroid cancer	3.08e-05	0.00221	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—MINPP1—thyroid cancer	3e-05	0.00215	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	2.99e-05	0.00214	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—MINPP1—thyroid cancer	2.93e-05	0.0021	CbGpPWpGaD
Voriconazole—CYP2C9—Biological oxidations—RXRA—thyroid cancer	2.81e-05	0.00201	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—SLC5A5—thyroid cancer	2.78e-05	0.00199	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—HPGD—thyroid cancer	2.61e-05	0.00187	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—NDUFA13—thyroid cancer	2.55e-05	0.00183	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—HPGD—thyroid cancer	2.53e-05	0.00181	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—NDUFA13—thyroid cancer	2.49e-05	0.00179	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—CHST14—thyroid cancer	2.4e-05	0.00172	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—CHST14—thyroid cancer	2.34e-05	0.00168	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—RXRA—thyroid cancer	2.33e-05	0.00167	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—MINPP1—thyroid cancer	2.27e-05	0.00162	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—MINPP1—thyroid cancer	2.07e-05	0.00148	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—PPARG—thyroid cancer	2.06e-05	0.00148	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.05e-05	0.00147	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—HPGD—thyroid cancer	1.93e-05	0.00138	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—NDUFA13—thyroid cancer	1.93e-05	0.00138	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—HPGD—thyroid cancer	1.89e-05	0.00135	CbGpPWpGaD
Voriconazole—CYP3A4—Biological oxidations—RXRA—thyroid cancer	1.86e-05	0.00133	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—CHST14—thyroid cancer	1.81e-05	0.0013	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—NDUFA13—thyroid cancer	1.76e-05	0.00126	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—CHST14—thyroid cancer	1.65e-05	0.00118	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—PTGS2—thyroid cancer	1.62e-05	0.00116	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—TPR—thyroid cancer	1.5e-05	0.00108	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	1.48e-05	0.00106	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—PPARG—thyroid cancer	1.47e-05	0.00105	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—HPGD—thyroid cancer	1.46e-05	0.00105	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—TPR—thyroid cancer	1.45e-05	0.00104	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—PRKAR1A—thyroid cancer	1.43e-05	0.00103	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—PTEN—thyroid cancer	1.41e-05	0.00101	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—MINPP1—thyroid cancer	1.36e-05	0.000976	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—HPGD—thyroid cancer	1.33e-05	0.000954	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.3e-05	0.000929	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.18e-05	0.000848	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.16e-05	0.00083	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—PTGS2—thyroid cancer	1.16e-05	0.00083	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—SLC5A5—thyroid cancer	1.12e-05	0.000805	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—TPR—thyroid cancer	1.11e-05	0.000795	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	1.09e-05	0.000782	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—CHST14—thyroid cancer	1.09e-05	0.00078	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—SLC5A5—thyroid cancer	1.09e-05	0.00078	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—TPR—thyroid cancer	1.08e-05	0.000777	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.08e-05	0.000774	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	1.07e-05	0.000765	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.02e-05	0.000731	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—PTEN—thyroid cancer	1.01e-05	0.000724	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—RXRA—thyroid cancer	9.44e-06	0.000676	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—RXRA—thyroid cancer	9.15e-06	0.000655	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.9e-06	0.000637	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—HPGD—thyroid cancer	8.78e-06	0.000629	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—TPR—thyroid cancer	8.39e-06	0.000601	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—SLC5A5—thyroid cancer	8.31e-06	0.000595	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	8.25e-06	0.000591	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—AKT1—thyroid cancer	8.14e-06	0.000583	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—SLC5A5—thyroid cancer	8.12e-06	0.000582	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—TPR—thyroid cancer	7.65e-06	0.000548	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	7.52e-06	0.000539	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	7.48e-06	0.000536	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—RXRA—thyroid cancer	6.98e-06	0.0005	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—RXRA—thyroid cancer	6.82e-06	0.000489	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.82e-06	0.000488	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—SLC5A5—thyroid cancer	6.28e-06	0.00045	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—PPARG—thyroid cancer	5.96e-06	0.000427	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.88e-06	0.000421	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—AKT1—thyroid cancer	5.82e-06	0.000417	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—PPARG—thyroid cancer	5.78e-06	0.000414	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—SLC5A5—thyroid cancer	5.73e-06	0.00041	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.36e-06	0.000384	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—RXRA—thyroid cancer	5.28e-06	0.000378	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.13e-06	0.000368	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—TPR—thyroid cancer	5.04e-06	0.000361	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	4.96e-06	0.000355	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—RXRA—thyroid cancer	4.81e-06	0.000345	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—PTGS2—thyroid cancer	4.69e-06	0.000336	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.68e-06	0.000335	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—PTGS2—thyroid cancer	4.54e-06	0.000326	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—PPARG—thyroid cancer	4.41e-06	0.000316	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—PPARG—thyroid cancer	4.31e-06	0.000309	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—PTEN—thyroid cancer	4.09e-06	0.000293	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—PTEN—thyroid cancer	3.96e-06	0.000284	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—SLC5A5—thyroid cancer	3.78e-06	0.00027	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—PTGS2—thyroid cancer	3.47e-06	0.000248	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—PTGS2—thyroid cancer	3.39e-06	0.000243	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—PPARG—thyroid cancer	3.33e-06	0.000239	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—RXRA—thyroid cancer	3.17e-06	0.000227	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—PPARG—thyroid cancer	3.04e-06	0.000218	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—PTEN—thyroid cancer	3.02e-06	0.000217	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—PTEN—thyroid cancer	2.96e-06	0.000212	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—PTGS2—thyroid cancer	2.62e-06	0.000188	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—PTGS2—thyroid cancer	2.39e-06	0.000171	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—AKT1—thyroid cancer	2.36e-06	0.000169	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—PTEN—thyroid cancer	2.29e-06	0.000164	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—AKT1—thyroid cancer	2.28e-06	0.000164	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—PTEN—thyroid cancer	2.08e-06	0.000149	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—PPARG—thyroid cancer	2e-06	0.000143	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—AKT1—thyroid cancer	1.74e-06	0.000125	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—AKT1—thyroid cancer	1.7e-06	0.000122	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.58e-06	0.000113	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—PTEN—thyroid cancer	1.37e-06	9.84e-05	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—AKT1—thyroid cancer	1.32e-06	9.43e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—AKT1—thyroid cancer	1.2e-06	8.6e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—AKT1—thyroid cancer	7.92e-07	5.67e-05	CbGpPWpGaD
